Medicines
Malignant Disease and Immunosuppression
Drugs affecting the immune response
Alemtuzumab

Alemtuzumab

Malignant Disease and Immunosuppression Drugs affecting the immune response BNF 0802030E0

Data updated June 2023 Download CSV

1items

Dispensed in June 2023

0items

Rolling 12 months

£7,045

Net ingredient cost · June 2023

Figure 1. Alemtuzumab: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to June 2023

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/alemtuzumab-0802030e0" width="100%" height="280" style="border:0" loading="lazy" title="Alemtuzumab: NHS prescribing in England — PharmaInsight"></iframe>
<p style="font-size:13px;margin-top:4px">Chart: <a href="https://pharmainsight.co.uk/medicines/alemtuzumab-0802030e0">PharmaInsight</a> · Data: NHSBSA Prescription Cost Analysis</p>

Free to reuse with the credit line above.

At a glance

Therapeutic class Drugs affecting the immune response
Presentations 1 shown
Average cost / item £7,045.00

What this is

Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Where Alemtuzumab is dispensed

The regions and dispensing practices with the highest Alemtuzumab volumes.

Top regions

NHS North East London Integrated Care Board 1

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Alemtuzumab with

Other medicines in the same BNF section, by prescribing volume.

Alemtuzumab vs Azathioprine Alemtuzumab vs Mycophenolate mofetil Alemtuzumab vs Tacrolimus Alemtuzumab vs Ciclosporin Alemtuzumab vs Mycophenolic sodium

Download this data

The monthly series for Alemtuzumab is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.